Johnson & Johnson (NYSE:JNJ) today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in ...

Administration of PEDMARK® Approximately Six Hours After Cisplatin was Shown to Be Safe & Easily Integrated into Care for Adults with Head & Neck Cancers (HNC) - ...

April marks the beginning of Oral & Head and Neck Cancer Awareness Month. This year, more than 50,000 new cases are expected to be diagnosed in the US. Specialists often refer to head and neck cancer ...

April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care. April is Head and Neck Cancer Awareness Month, ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

A senior oncologist says Northeast India records the highest cancer incidence in the country, particularly oral, head and ...

The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for subcutaneous Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as a monotherapy for adults with advanced ...

While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee and tea we drink can have a protective effect, reducing the risk of ...

Last year the Association of Dental Groups which represents more than 2,000 practices in the UK told MPs that 4.5m patients ...

What Is Tongue Cancer? Symptoms, Causes, Diagnosis, Treatment, and PreventionMedically Reviewed by Walter Tsang, MD | October 11, 2023 What Is Head and Neck Cancer? Causes, Symptoms, Diagnosis, ...